Bookmarks

Development of ELISA and Rapid Testing Kits for COVID-19

Population Size

Not reported
Population Size statistic card

Years

2021 - 2021

Years statistic card

Associated BioSamples

None/not available

Associated BioSamples statistic card

Geographic coverage

Pakistan

Geographic coverage statistic card

Lead time

Not applicable

Lead time statistic card

Summary

This project aims to develop ELISA based detection kits for the detection of viral antigen of COVID-19, and separately to detect the immune response to COVID-19 infection. To be marketed in Pakistan.

Documentation

The electronic data will consist of documenting the different diagnostic reagents imported, with their technical details, specifications and expiry dates. A record will be kept of the use of these reagents, and their performance characteristics in the research laboratory. The second main data set will involve the development of the diagnostic kits, and documentation of all physical, chemical and immunological parameters around each diagnostic procedure, and the outcomes, and whether success or failure. The third set of data will be generated when the developed diagnostic kits are tested against the known samples received from the commercial (Metropole) laboratories and the results compared.

Dataset type

Health and disease

Dataset sub-type

Not applicable

Keywords

Observations

Observed Node

Disambiguating Description

Measured Value

Measured Property

Observation Date

Findings

Observations Not Applicable at this time (Oct 2021) and default values used where fields are mandatory

1

Count

30 Nov 2021

Provenance

Source of data extraction

Other

Collection source setting

Other

Patient pathway description

Human tissue samples collected from patients who attend routine diagnostic procedures at commercial laboratories and hospitals, especially for COVID related tests

Image contrast

Not stated

Biological sample availability

None/not available

Details

Publishing frequency

Static

Version

1.0.0

Modified

08/10/2024

Citation Requirements

RESPIRE Collaboration

Coverage

Start date

15/08/2021

End date

30/11/2021

Time lag

Not applicable

Geographic coverage

Pakistan

Maximum age range

150

Accessibility

Language

en

Controlled vocabulary

LOCAL

Format

CSV

Data Access Request

Dataset pipeline status

Not available

Time to dataset access

Not applicable

Access method category

Varies based on project

Access service description

Access is managed on a project-by-project basis. Contact the RESPIRE Collaboration.

Jurisdiction

PK

Data use limitation

No restriction

Data Controller

RESPIRE

Data Processor

RESPIRE

Dataset Types: Health and disease


Collection Sources: Other

end of page